<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Many patients with <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) receive <z:chebi fb="0" ids="2663">amiodarone</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="2663">Amiodarone</z:chebi>-induced <z:hpo ids='HP_0000836'>hyperthyroidism</z:hpo> (AIH) may develop as a complication </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that pulmonary vein (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>) isolation in patients with paroxysmal AF and history of AIH may yield a lower success rate </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: Among 704 patients who underwent AF ablation in our center between 2007 and 2010, we identified 20 patients (mean age 58.3 Â± 5.0 years; 11 males) with paroxysmal AF and overt AIH in the past </plain></SENT>
<SENT sid="4" pm="."><plain>The control group consisted of 40 patients with <z:chebi fb="0" ids="2663">amiodarone</z:chebi>-refractory AF and no thyroid dysfunction </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent circumferential <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation </plain></SENT>
<SENT sid="6" pm="."><plain>During redo procedures <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0001649'>tachycardias</z:hpo> were targeted for ablation </plain></SENT>
<SENT sid="7" pm="."><plain>During a 12-month follow-up, in the AIH group 6 (30%) patients were <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> free after a single procedure, in comparison to 25 (62.5%) controls (P = 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>Atrial <z:hpo ids='HP_0001649'>tachycardia</z:hpo> (AT) was registered in 7 (35%) AIH patients and in 1 (2.5%) control patient (P = 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>AF recurred in 10 (50%) AIH versus 15 (37.5%) control patients (P = 0.2) </plain></SENT>
<SENT sid="10" pm="."><plain>Redo ablation was performed in 7 (35%) AIH patients and in 3 (7.5%) non-AIH patients (P = 0.01) </plain></SENT>
<SENT sid="11" pm="."><plain>During a redo procedure a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>-unrelated <z:hpo ids='HP_0001649'>tachycardia</z:hpo> was diagnosed in 5 (25%) AIH patients (vs 0 in the controls, P = 0.003) </plain></SENT>
<SENT sid="12" pm="."><plain>After the last performed ablation, 12 (60%) AIH patients and 28 (70%) controls had no recurrence, P = 0.56 </plain></SENT>
<SENT sid="13" pm="."><plain>AIH was an independent predictor of ATs </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> isolation alone has a lower efficacy for preventing recurrence in paroxysmal AF in AIH patients </plain></SENT>
<SENT sid="15" pm="."><plain>After repeat ablations, overall freedom from tachyarrhythmias is similar to patients with no history of thyroid dysfunction </plain></SENT>
</text></document>